Khaled Alhosaini

1.9k total citations
44 papers, 794 citations indexed

About

Khaled Alhosaini is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Khaled Alhosaini has authored 44 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Khaled Alhosaini's work include Autism Spectrum Disorder Research (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and COVID-19 Clinical Research Studies (4 papers). Khaled Alhosaini is often cited by papers focused on Autism Spectrum Disorder Research (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and COVID-19 Clinical Research Studies (4 papers). Khaled Alhosaini collaborates with scholars based in Saudi Arabia, India and United States. Khaled Alhosaini's co-authors include Othman A. Al‐Shabanah, Naif O. Al‐Harbi, Mohamed M. Sayed‐Ahmed, Mohamed M. Hafez, Sheikh F. Ahmad, Sabry M. Attia, Ahmed Nadeem, Mushtaq Ahmad Ansari, Hatem M. Abuohashish and Mohammed M. Ahmed and has published in prestigious journals such as The FASEB Journal, International Journal of Molecular Sciences and Molecular Pharmacology.

In The Last Decade

Khaled Alhosaini

43 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khaled Alhosaini Saudi Arabia	16	278	130	88	85	76	44	794
Chiu-Yuan Chen Taiwan	13	298 1.1×	105 0.8×	83 0.9×	55 0.6×	50 0.7×	16	871
Wutigri Nimlamool Thailand	18	329 1.2×	107 0.8×	155 1.8×	61 0.7×	60 0.8×	52	833
Anna Bogacz Poland	15	296 1.1×	68 0.5×	108 1.2×	107 1.3×	82 1.1×	102	919
Muhammad Rizwan Sweden	9	366 1.3×	91 0.7×	80 0.9×	71 0.8×	49 0.6×	12	938
Nasrin Maleki‐Dizaji Iran	20	438 1.6×	116 0.9×	87 1.0×	117 1.4×	136 1.8×	45	1.1k
Hemanth Kumar Kandikattu United States	21	336 1.2×	180 1.4×	106 1.2×	137 1.6×	107 1.4×	67	1.3k
Yanxi Zhou China	10	377 1.4×	70 0.5×	116 1.3×	64 0.8×	43 0.6×	16	964
Jingyi Tang China	17	363 1.3×	90 0.7×	56 0.6×	93 1.1×	71 0.9×	57	886
Sherine M. Rizk Egypt	20	399 1.4×	58 0.4×	70 0.8×	99 1.2×	65 0.9×	42	1.0k

Countries citing papers authored by Khaled Alhosaini

Since Specialization

Citations

This map shows the geographic impact of Khaled Alhosaini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Alhosaini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Alhosaini more than expected).

Fields of papers citing papers by Khaled Alhosaini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Alhosaini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Alhosaini. The network helps show where Khaled Alhosaini may publish in the future.

Co-authorship network of co-authors of Khaled Alhosaini

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Alhosaini. A scholar is included among the top collaborators of Khaled Alhosaini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Alhosaini. Khaled Alhosaini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samad, Md Abdus, Mohd Suhail, Torki A. Zughaibi, et al.. (2025). Breast Cancer: Molecular Pathogenesis and Targeted Therapy. MedComm. 6(10). e70404–e70404. 2 indexed citations

Bakheet, Tala, et al.. (2025). A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients. International Journal of Molecular Sciences. 26(3). 1017–1017.

Khan, M. S., et al.. (2023). Inhibitory Potential of Carnosine and Aminoguanidine Towards Glycation and Fibrillation of Albumin: In-vitro and Simulation Studies. Journal of Fluorescence. 35(1). 29–42. 2 indexed citations

Alafaleq, Nouf Omar, et al.. (2023). Evaluation of biogenically synthesized MgO NPs anticancer activity against breast cancer cells. Saudi Journal of Biological Sciences. 31(1). 103874–103874. 26 indexed citations

Alhazzani, Khalid, Khaldoon Aljerian, Khaled Alhosaini, et al.. (2023). Hydroxychloroquine ameliorates dasatinib-induced liver injury via decrease in hepatic lymphocytes infiltration. Human & Experimental Toxicology. 42. 3530206732–3530206732. 4 indexed citations

Almutairi, Mashal M., Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.. (2022). Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T+ Itpr3tf/J autistic mouse model. NeuroToxicology. 91. 340–348. 18 indexed citations

Al‐Harbi, Naif O., Faisal Imam, Mohammad M. Al-Harbi, et al.. (2022). Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation. Saudi Journal of Biological Sciences. 29(5). 3414–3424. 3 indexed citations

Al‐Mazroua, Haneen A., Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.. (2022). Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T+ Itpr3tf/J mouse model of autism. Immunology Letters. 244. 19–27. 9 indexed citations

Alhosaini, Khaled, et al.. (2021). GPCRs: The most promiscuous druggable receptor of the mankind. Saudi Pharmaceutical Journal. 29(6). 539–551. 45 indexed citations

10.

Alhosaini, Khaled, Mushtaq Ahmad Ansari, Ahmed Nadeem, et al.. (2021). 5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism. Brain Sciences. 11(2). 249–249. 16 indexed citations

11.

Ahmad, Sheikh F., Mushtaq Ahmad Ansari, Ahmed Nadeem, et al.. (2019). Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism. NeuroToxicology. 77. 1–11. 25 indexed citations

12.

Alhoshani, Ali, Khaled Alhosaini, Nehad M. Alajez, et al.. (2018). Gold-containing compound BDG-I inhibits the growth of A549 lung cancer cells through the deregulation of miRNA expression. Saudi Pharmaceutical Journal. 26(7). 1035–1043. 6 indexed citations

13.

Ahmad, Sheikh F., Mushtaq Ahmad Ansari, Ahmed Nadeem, et al.. (2018). Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism. International Immunopharmacology. 65. 360–365. 12 indexed citations

14.

Alhosaini, Khaled, et al.. (2016). Differential Effects of Camel Milk on Insulin Receptor Signaling – Toward Understanding the Insulin-Like Properties of Camel Milk. Frontiers in Endocrinology. 7. 4–4. 45 indexed citations

15.

Nadeem, Ahmed, Naif O. Al‐Harbi, Mohamed M. Al-Harbi, et al.. (2015). Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacological Research. 99. 248–257. 98 indexed citations

16.

Mansour, Mahmoud, et al.. (2014). Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma. Chemico-Biological Interactions. 215. 17–24. 13 indexed citations

17.

Ayoub, Mohammed Akli, Fabienne Charrier‐Savournin, Khaled Alhosaini, et al.. (2014). Homogeneous Time-Resolved Fluorescence-Based Assay to Monitor Extracellular Signal-Regulated Kinase Signaling in a High-Throughput Format. Frontiers in Endocrinology. 5. 94–94. 17 indexed citations

18.

Attia, Sabry M., Sheikh F. Ahmad, Khairy M. A. Zoheir, et al.. (2013). Genotoxic evaluation of chloroacetonitrile in murine marrow cells and effects on DNA damage repair gene expressions. Mutagenesis. 29(1). 55–62. 24 indexed citations

19.

Abuohashish, Hatem M., Salim S. Al‐Rejaie, Khaled Alhosaini, Mihir Parmar, & Mohammed M. Ahmed. (2013). Alleviating effects of morin against experimentally-induced diabetic osteopenia. Diabetology & Metabolic Syndrome. 5(1). 5–5. 62 indexed citations

20.

Aleisa, Abdulaziz M., Mohamed M. Sayed‐Ahmed, Othman A. Al‐Shabanah, et al.. (2013). Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat. BMC Complementary and Alternative Medicine. 13(1). 136–136. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact